Nonagen Bioscience Corporation
Biotechnology
Website
Company Tagline
Working to reduce the global burden of cancer with innovative diagnostics
Industry Category
Business Keywords
Company Description
Nonagen Bioscience Corporation is at the forefront of biotechnology, dedicated to reducing the global impact of cancer through the development of innovative diagnostics. Focused on pioneering research and the creation of first-in-class diagnostic tools, Nonagen Bioscience Corporation aims to revolutionize early cancer detection and prediction.
Leveraging a profound understanding of biomarker discovery and validation, Nonagen Bioscience Corporation is committed to enhancing clinical outcomes and advancing cancer management. Their lead diagnostic, Oncuria®, exemplifies this dedication. Oncuria® is a cutting-edge, urine-based liquid biopsy designed for the noninvasive detection of bladder cancer, measuring 10 key biomarkers associated with the disease. The primary address of Nonagen Bioscience Corporation is 3680 Wilshire Blvd, Ste P04, Los Angeles, California 90010, US.
Nonagen Bioscience Corporation is developing Oncuria to support bladder cancer diagnosis, monitor recurrence in early-stage patients, and predict treatment response to intravesical bacillus Calmette-Guérin (BCG) therapy. The FDA's Breakthrough Device Designation for Oncuria underscores its potential to transform bladder cancer diagnostics. We invite the management of Nonagen Bioscience Corporation to enhance their visibility by creating a customized and exclusive company showcase and product listing on our platform.
Nonagen Bioscience Corporation est à l'avant-garde de la biotechnologie, dédiée à la réduction de l'impact mondial du cancer grâce au développement de diagnostics innovants. Axée sur la recherche pionnière et la création d'outils de diagnostic de premier ordre, Nonagen Bioscience Corporation vise à révolutionner la détection et la prédiction précoces du cancer.
Mettant à profit une compréhension approfondie de la découverte et de la validation des biomarqueurs, Nonagen Bioscience Corporation s'engage à améliorer les résultats cliniques et à faire progresser la gestion du cancer. Son principal outil de diagnostic, Oncuria®, illustre cet engagement. Oncuria® est une biopsie liquide de pointe à base d'urine conçue pour la détection non invasive du cancer de la vessie, mesurant 10 biomarqueurs clés associés à la maladie. L'adresse principale de Nonagen Bioscience Corporation est 3680 Wilshire Blvd, Ste P04, Los Angeles, Californie 90010, États-Unis.
Nonagen Bioscience Corporation développe Oncuria pour soutenir le diagnostic du cancer de la vessie, surveiller la récidive chez les patients à un stade précoce et prédire la réponse au traitement par le bacille Calmette-Guérin (BCG) intravésical. La désignation de dispositif révolutionnaire de la FDA pour Oncuria souligne son potentiel de transformation du diagnostic du cancer de la vessie. Nous invitons la direction de Nonagen Bioscience Corporation à améliorer sa visibilité en créant une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme.
Key Personnel / Employees
Compare Companies Side by Side
Compare Nonagen Bioscience Corporation with 3 companies in Biotechnology
| Comparison Field |
Nonagen Bioscience Corpor...Main Company |
Singlera Genomics In...View Profile |
Pacific Edge LtdView Profile |
GEAGEN HEALTH & BIOT...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2013 | 2001 | |
|
Company Size
|
— | 11-50 | 51-200 | 2-10 |
|
City
|
Los Angeles, California | La Jolla, California | Dunedin, Otago | |
|
Country
|
United States | United States | New Zealand | |
|
Skills & Keywords
Comparing with main company
|
16 Total Skills
Biotechnology
Cancer Diagnostics
Liquid Biopsy
Molecular Diagnostics
In Vitro Diagnostics
Oncology
Biomarker Discovery
molecular diagnostics
in vitro diagnostics
multiplex immunoassays
cancer diagnostics
bladder cancer diagnostics
urine testing
cancer prognostics
commercialization
liquid biopsy
|
4 Total
4 Unique
Unique Skills:
assay development
cell-free DNA
methylation haplotyping
NGS
|
2 Total
2 Unique
Unique Skills:
commercialisation
genomic urine testing
|
18 Total
18 Unique
Unique Skills:
cancer
cancer diagnosis & monitoring
cancer molecular monitoring
cancer surgery
cancer treatment
genetic
+12
|
4
Total Companies2001
Oldest Founded2
Countries40
Unique SkillsSimilar Companies
Other organizations in the same industry
ZKTeco Colombia
BiotechnologyFabricante y líder mundial en Biometría híbrida, Control de Acceso, Reconocimiento Facial, POS, CCTV
MAIA Biotechnology, Inc.
BiotechnologyMAIA Biotechnology is a targeted therapy, immuno-oncology company focused on development of first-in...
Alternative Company Names
This company is also known as